Detalhe da pesquisa
1.
Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
Am Heart J
; 253: 59-66, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835265
2.
The effect of increased plasma potassium on myocardial function; a randomized POTCAST substudy.
Int J Cardiovasc Imaging
; 39(11): 2097-2106, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470856
3.
Global constructive work is associated with ventricular arrhythmias after cardiac resynchronization therapy.
Eur Heart J Cardiovasc Imaging
; 25(1): 29-36, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490039
4.
Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudy.
PLoS One
; 18(7): e0288756, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467227
5.
Treatment patterns for oral anticoagulants in older patients with atrial fibrillation: a retrospective, cross-sectional, nationwide study from Denmark.
BMJ Open
; 12(9): e062353, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581981